MannKind | MNKD - DETTE





DETTE Changement Date
Adma Biologics USD 83.12M 702K 2025-09
BioCryst Pharmaceuticals USD 828.6M 510K 2024-12
Eli Lilly USD 42.51B 2.6B 2025-09
Halozyme Therapeutics USD 1.51B 1.66M 2025-09
Insmed USD 727.89M 163.33M 2025-12
Karyopharm Therapeutics USD 264.09M 39.31M 2024-09
MacroGenics USD 37.01M 238K 2025-09
MannKind USD 119.91M 73.09M 2025-09
Merck USD 41.37B 5.97B 2025-09
Minerva Neurosciences USD 0 0 2024-09
Novavax USD 233.31M 4.23M 2024-09
Novo Nordisk DKK 118.72B 15.94B 2025-03
Pfizer USD 60.85B 78M 2025-09
Sanofi EUR 21.76B 530M 2025-09
Xencor USD 69.27M 1.34M 2025-09